SCHEMBL4434705

SCHEMBL4434705

CC(=O)c1ccc2c(c1)[nH]c(=O)n2C1CCNCC1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
HSD11B1 P28845 6/20 0.47
YEATS4 O95619 2/20 0.46
KCNH2 Q12809 2/20 0.46
PLD1 Q13393 7/20 0.46
PLD2 O14939 6/20 0.46
SIRT2 Q8IXJ6 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
DRD2 P14416 1/20 0.45
HTR2A P28223 1/20 0.45
SLC6A4 P31645 1/20 0.45
DRD3 P35462 1/20 0.45
MLLT3 P42568 1/20 0.44
MLLT1 Q03111 1/20 0.44
YEATS2 Q9ULM3 1/20 0.44
CHRM1 P11229 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3134355 0.88 USP2 (0.58) USP2ALDH1A1LMNAHSD11B1YEATS4
SCHEMBL7190435 0.87 USP2 (0.55) USP2ALDH1A1LMNAHSD11B1YEATS4
SCHEMBL7190427 0.87 USP2 (0.55) USP2ALDH1A1LMNAHSD11B1YEATS4
SCHEMBL13153966 0.86 ALDH1A1 (0.57) USP2ALDH1A1LMNAHSD11B1YEATS4
SCHEMBL4439012 0.86 USP2 (0.63) USP2ALDH1A1LMNAHSD11B1YEATS4
Hydrochloric Acid SCHEMBL29848399 0.85 ALDH1A1 (0.56) USP2ALDH1A1LMNAHSD11B1YEATS4
SCHEMBL14498216 0.84 OPRM1 (0.54) USP2ALDH1A1LMNAPLD1PLD2
SCHEMBL14008572 0.83 YEATS4 (0.66) USP2ALDH1A1LMNAYEATS4KCNH2
SCHEMBL30870639 0.81 SIRT2 (0.49) USP2ALDH1A1LMNAPLD1PLD2
SCHEMBL1760904 0.81 OPRM1 (0.57) USP2ALDH1A1LMNAKCNH2SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121656-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE Pfizer Products Inc. (US) 2009-11-25 EP disclosed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed
WO-2008084300-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER PRODUCTS INC. (US) 2008-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE SPTLC1, SPTLC2, CPT1A USP2 896/4885ALDH1A1 2622/4885LMNA 2105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.